Global X S&P Biotech ETF - Managed Fund

Fund Objective

The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Fund Strategy

The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}

Peers

Benchmark ({{ fund.benchmark.name }})

{{ fund.model.name }}

The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.

Fees Comparison

% p.a.

Average of peers ({{ fund.benchmark.peers.peerCount }})

NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.

Fund performance

	1M	3M	6M	1Y p.a.	2Y p.a.	3Y p.a.	5Y p.a.	10Y p.a.
Total return	-2.68%	3.49%	33.94%	19.77%	15.75%	11.91%	-2.36%	-%
Growth return	-1.47%	-6.3%	27.96%	22.9%	7.55%	12.4%	-3.7%	-%
Income return	-1.21%	9.79%	5.98%	-3.13%	8.2%	-0.49%	1.34%	-%
Market index (MSCI World Ex Australia NR AUD)
Total return	-0.9%	2.55%	8.85%	12.53%	21.5%	22.08%	15.57%	13.23%

As at 31 Jan 2026. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Global X S&P Biotech ETF

International Equities: 100%

Australian Equities: 0%

Cash: 0%

Property & Infrastructure: 0%

Fixed Interest: 0%

Alternatives: 0%

Average Allocation of Peers

International Equities: 90.04%

Australian Equities: 7.77%

Cash: 1.67%

Property & Infrastructure: 0.24%

Fixed Interest: -0.01%

Alternatives: 0.29%

General Information

Fund Details

Type	Description
Fund Name	Global X S&P Biotech ETF
Responsible Entity	ANZ ETFS Management (AUS) Ltd
APIR Code
Sector/Asset Class	Equity World Other
Morningstar Rating	Not Rated
Legal Structure	Investment Fund
Fund Inception	8 Nov 2018
Fund Size	$39035245 million (as at 12 Feb 2026)
Entry Price	$42.5 (as at 30 Aug 2023)
Exit Price	$40 (as at 30 Aug 2023)
Fund Status	Open

Offer information

Type	Description
MER	0.45% (as at 13 Jan 2026)
Indirect Cost Ratio (ICR)	0.45% (as at 30 Jun 2025)
Minimum initial investment	$500.00

Top 10 holdings (as at 13 Feb 2026)

Holding (as at 13 Feb 2026)	Type	% of Portfolio
Moderna Inc		1.72%
Login now to view the complete list of holdings.

Your guide to next steps

Dealing with a struggling fund? What to Do and Look For

How to Assess your Managed Fund: And How to Choose the Next One

Your managed fund switching checklist. Is fear of capital gains tax holding you back?

The Great Investment Fee Scam is hiding in plain sight. And it's ripping us all off.

Guide to tidying up your Portfolio Manager holdings

FAQs about the Global X S&P Biotech ETF

What is the objective of the Global X S&P Biotech ETF managed fund?

The objective of the Global X S&P Biotech ETF managed fund is The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

What is the strategy for the Global X S&P Biotech ETF managed fund?

The strategy of the Global X S&P Biotech ETF managed fund is The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

What is the APIR code of the Global X S&P Biotech ETF managed fund?

The APIR code of the Global X S&P Biotech ETF managed fund is .

What was Global X S&P Biotech ETF’s total return last month?

Global X S&P Biotech ETF’s total return last month was -2.68%. This was made up of a growth return of -1.47% and an income return of -1.21%. These returns were calculated as at 31 Jan 2026.

What was Global X S&P Biotech ETF’s total return for the last three months?

Global X S&P Biotech ETF’s total return for the last three months was 3.49%. This was made up of a growth return of -6.3% and an income return of 9.79%%. These returns were calculated as at 31 Jan 2026.

What is Global X S&P Biotech ETF’s one-year total return?

Global X S&P Biotech ETF’s one-year total return is 19.77%. This was made up of a growth return of 22.9% and an income return of -3.13%. These returns were calculated as at 31 Jan 2026.

What is Global X S&P Biotech ETF’s three-year total return?

Global X S&P Biotech ETF’s one-year total return is 11.91%. This was made up of a growth return of 12.4% and an income return of -0.49%. These returns were calculated as at 31 Jan 2026.

What is the asset allocation of the Global X S&P Biotech ETF managed fund?

The asset allocation of the Global X S&P Biotech ETF managed fund is :

International Equities: 100%

Australian Equities: 0%

Cash: 0%

Property & Infrastructure: 0%

Fixed Interest: 0%

Alternatives: 0%

Who is the responsible Entity of the Global X S&P Biotech ETF managed fund?

The Responsible Entity for the Global X S&P Biotech ETF managed fund is ANZ ETFS Management (AUS) Ltd.

What sector/asset class does the Global X S&P Biotech ETF managed fund belong to?

The Global X S&P Biotech ETF managed fund belongs to the Equity World Other sector/asset class.

What is the size of the Global X S&P Biotech ETF managed fund?

As at 12 Feb 2026, the size of the Global X S&P Biotech ETF managed fund was $39035245 million.

What is the inception date of the Global X S&P Biotech ETF managed fund?

The Global X S&P Biotech ETF managed fund has an inception date of 8 Nov 2018.

What is the current entry price of the Global X S&P Biotech ETF managed fund?

The current entry price of the Global X S&P Biotech ETF managed fund is $42.5 per unit and the current exit price is $40 per unit (as at 30 Aug 2023).

What is the current exit price of the Global X S&P Biotech ETF managed fund?

The current exit price of the Global X S&P Biotech ETF managed fund is $40 per unit and the current entry price is $42.5 per unit (as at 30 Aug 2023).

What is the minimum investment amount for the Global X S&P Biotech ETF managed fund?

The minimum initial investment amount for the Global X S&P Biotech ETF managed fund is $500.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.

What our members say about us